Dr. Jerome J. Graber, MD, MPH

Dr. Graber practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Dr. Graber's NPI, 1770782385, was assigned on July 13, 2007. Dr. Graber graduated from University of Maryland School of Medicine - Baltimore in 2005. Dr. Graber holds Washington license MD60623976.

Dr. Graber's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Dr. Graber's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. The medical group on file is UW Physicians. Dmand AI also links Dr. Graber to 1 more hospital and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Graber practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Graber's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Graber is board certified in hospice and palliative medicine by the American Board of Internal Medicine. Dmand AI has Dr. Graber's licenses on file in 4 states: Washington, Idaho, Montana and New York.

Dmand AI lists epilepsy among the conditions Dr. Graber treats.

CMS data shows 147 Medicare services from Dr. Graber across 3 procedure codes in 2024, for 71 Medicare patients. Medicare paid $11,452 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 71 Medicare patients who saw Dr. Graber in 2024. The largest group is 65 to 74, with 33 patients. 58% of them have high cholesterol, and 52% have high blood pressure. 17% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Graber's median patient age at 50, with 51% women.

In 2024, Dr. Graber wrote 230 Medicare Part D claims for 53 patients. 93% of them were for generic drugs. CMS names the drug for 131 of them, across 5 drugs with 11 or more claims each, at $4,165 in total drug cost. In 2023, CMS named 175 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Graber for performance year 2024, reported through an alternative payment model (APM). Dr. Graber accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Graber as offering telehealth.

Dmand AI links 65 papers to Dr. Graber, published from 2010 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Brain Neoplasms, Magnetic Resonance Imaging and Glioblastoma. Dr. Graber has published most often in J Neurooncol. Dr. Graber's most frequent co-authors are Antonio Marcilio Padula Omuro, MD, Alipi Vesselinov Naydenov Bonm, MD, PhD and Lynne P. Taylor, MD.

Dmand AI links Dr. Graber to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Glioblastoma, Astrocytoma and Gliosarcoma.

CMS Open Payments shows 26 general payments to Dr. Graber from 7 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 36% of the total. Novocure Inc. paid the most, $4,615.

Dmand AI lists 2 awards for Dr. Graber, most recently FAAN in 2022.

Dr. Graber graduated from University of Maryland School of Medicine - Baltimore in 2005. Dr. Graber is a member of ASCO.

Dr. Graber is in network with 17 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.